Regulatory peptides as a source of new drugs — the clinical prospects for analogues of TRH which are resistant to metabolic degradation
- 30 November 1982
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 4 (3), 389-408
- https://doi.org/10.1016/0165-0173(82)90012-1
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Thyrotropin-Releasing HormoneNew England Journal of Medicine, 1982
- Effect of thyrotropin-releasing hormone on gastro-intestinal secretions in dogsLife Sciences, 1981
- Thyrotropin-Releasing Hormone Improves Neurologic Recovery after Spinal Trauma in CatsNew England Journal of Medicine, 1981
- Thyrotropin releasing factor: A putative CNS regulator of the automatic nervous systemLife Sciences, 1981
- γ-butyrolactone-γ-carbonyl-histidyl-prolinamide citrate (DN-1417) : A novel TRH analog with potent effects on the central nervous systemLife Sciences, 1981
- Effect of melanostatin and thyroliberin on the biosynthesis and release of dopamine by rat brain striatal P2 fractionsLife Sciences, 1980
- Differential mode of action of thyrotropin-releasing hormone and enkephalin on the smooth muscle of rat duodenumLife Sciences, 1980
- Extrahypothalamic Thyrotropin Releasing Hormone (TRH) — Its distribution and its functionsLife Sciences, 1979
- A possible mechanism for the anti-depressant activity of thyrotropin releasing hormoneLife Sciences, 1974
- Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamideBiochemical and Biophysical Research Communications, 1971